Shreyansh Shah1,2, Ying Xian1,2, Shubin Sheng3, Kori S Zachrison, Jeffrey L Saver4, Kevin N Sheth5, Gregg C Fonarow6, Lee H Schwamm7, Eric E Smith8. 1. Department of Neurology, Duke University Hospital (S. Shah, Y.X.), Durham, NC. 2. Duke Clinical Research Institute (S. Shah, Y.X., S. Sheng), Durham, NC. 3. Department of Emergency Medicine (K.S.Z.), Massachusetts General Hospital, Boston. 4. Department of Neurology (J.L.S.), UCLA Medical Center, Los Angeles, CA. 5. Department of Neurology, Yale School of Medicine, New Haven, CT (K.N.S.). 6. Division of Cardiology (G.C.F.), UCLA Medical Center, Los Angeles, CA. 7. Department of Neurology (L.H.S.), Massachusetts General Hospital, Boston. 8. Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, AB, Canada (E.E.S.).
Abstract
BACKGROUND: The use of endovascular therapy (EVT) in patients with acute ischemic stroke who have large vessel occlusion has rapidly increased in the United States following pivotal trials demonstrating its benefit. Information about the contribution of interhospital transfer in improving access to EVT will help organize regional systems of stroke care. METHODS: We analyzed trends of transfer-in EVT from a cohort of 1 863 693 patients with ischemic stroke admitted to 2143 Get With The Guidelines-Stroke participating hospitals between January 2012 and December 2017. We further examined the association between arrival mode and in-hospital outcomes by using multivariable logistic regression models. RESULTS: Of the 37 260 patients who received EVT at 639 hospitals during the study period, 42.9% (15 975) arrived at the EVT-providing hospital after interhospital transfer. Transfer-in EVT cases increased from 256 in the first quarter 2012 to 1422 in the fourth quarter 2017, with sharply accelerated increases following the fourth quarter 2014 ( P<0.001 for change in linear trend). Transfer-in patients were younger and more likely to be of white race, to arrive during off-hours, and to be treated at comprehensive stroke centers. Transfer-in patients had significantly longer last-known-well-to-EVT initiation time (median, 289 minutes versus 213 minutes; absolute standardized difference, 67.33) but were more likely to have door-to-EVT initiation time of ≤90 minutes (65.6% versus 23.6%; absolute standardized difference, 93.18). In-hospital outcomes were worse for transfer-in patients undergoing EVT in unadjusted and in risk-adjusted models. Although the difference in in-hospital mortality disappeared after adjusting for delay in EVT initiation (14.7% versus 13.4%; adjusted odds ratio, 1.01; 95% CI, 0.92-1.11), transfer-in patients were still more likely to develop symptomatic intracranial hemorrhage (7.0% versus 5.7%; adjusted odds ratio, 1.15; 95% CI, 1.02-1.29) and less likely to have either independent ambulation at discharge (33.1% versus 37.1%; adjusted odds ratio, 0.87; 95% CI, 0.80-0.95) or to be discharged to home (24.3% versus 29.1%; adjusted odds ratio, 0.82; 95% CI, 0.76-0.88). CONCLUSIONS: Interhospital transfer for EVT is increasingly common and is associated with a significant delay in EVT initiation highlighting the need to develop more efficient stroke systems of care. Further evaluation to identify factors that impact EVT outcomes for transfer-in patients is warranted.
BACKGROUND: The use of endovascular therapy (EVT) in patients with acute ischemic stroke who have large vessel occlusion has rapidly increased in the United States following pivotal trials demonstrating its benefit. Information about the contribution of interhospital transfer in improving access to EVT will help organize regional systems of stroke care. METHODS: We analyzed trends of transfer-in EVT from a cohort of 1 863 693 patients with ischemic stroke admitted to 2143 Get With The Guidelines-Stroke participating hospitals between January 2012 and December 2017. We further examined the association between arrival mode and in-hospital outcomes by using multivariable logistic regression models. RESULTS: Of the 37 260 patients who received EVT at 639 hospitals during the study period, 42.9% (15 975) arrived at the EVT-providing hospital after interhospital transfer. Transfer-in EVT cases increased from 256 in the first quarter 2012 to 1422 in the fourth quarter 2017, with sharply accelerated increases following the fourth quarter 2014 ( P<0.001 for change in linear trend). Transfer-in patients were younger and more likely to be of white race, to arrive during off-hours, and to be treated at comprehensive stroke centers. Transfer-in patients had significantly longer last-known-well-to-EVT initiation time (median, 289 minutes versus 213 minutes; absolute standardized difference, 67.33) but were more likely to have door-to-EVT initiation time of ≤90 minutes (65.6% versus 23.6%; absolute standardized difference, 93.18). In-hospital outcomes were worse for transfer-in patients undergoing EVT in unadjusted and in risk-adjusted models. Although the difference in in-hospital mortality disappeared after adjusting for delay in EVT initiation (14.7% versus 13.4%; adjusted odds ratio, 1.01; 95% CI, 0.92-1.11), transfer-in patients were still more likely to develop symptomatic intracranial hemorrhage (7.0% versus 5.7%; adjusted odds ratio, 1.15; 95% CI, 1.02-1.29) and less likely to have either independent ambulation at discharge (33.1% versus 37.1%; adjusted odds ratio, 0.87; 95% CI, 0.80-0.95) or to be discharged to home (24.3% versus 29.1%; adjusted odds ratio, 0.82; 95% CI, 0.76-0.88). CONCLUSIONS: Interhospital transfer for EVT is increasingly common and is associated with a significant delay in EVT initiation highlighting the need to develop more efficient stroke systems of care. Further evaluation to identify factors that impact EVT outcomes for transfer-in patients is warranted.
Entities:
Keywords:
endovascular treatment; ischemic stroke; systems of care; treatment outcome
Authors: Eric E Smith; David M Kent; Ketan R Bulsara; Lester Y Leung; Judith H Lichtman; Mathew J Reeves; Amytis Towfighi; William N Whiteley; Darin B Zahuranec Journal: Stroke Date: 2018-01-24 Impact factor: 7.914
Authors: Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg Journal: N Engl J Med Date: 2018-01-24 Impact factor: 91.245
Authors: Benjamin P George; Sara J Doyle; George P Albert; Ania Busza; Robert G Holloway; Kevin N Sheth; Adam G Kelly Journal: Neurology Date: 2018-04-04 Impact factor: 9.910
Authors: Ryan A McTaggart; Shadi Yaghi; Shawna M Cutting; Morgan Hemendinger; Grayson L Baird; Richard A Haas; Karen L Furie; Mahesh V Jayaraman Journal: JAMA Neurol Date: 2017-07-01 Impact factor: 18.302
Authors: Matthew S W Milne; Jessalyn K Holodinsky; Michael D Hill; Anders Nygren; Chao Qiu; Mayank Goyal; Noreen Kamal Journal: Stroke Date: 2017-01-18 Impact factor: 7.914
Authors: Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan Journal: N Engl J Med Date: 2015-04-17 Impact factor: 91.245
Authors: John W Liang; Laura Stein; Natalie Wilson; Johanna T Fifi; Stanley Tuhrim; Mandip S Dhamoon Journal: J Neurointerv Surg Date: 2017-01-24 Impact factor: 5.836
Authors: Kessarin Panichpisal; Sarah Erpenbeck; Paul Vilar; Reji P Babygirija; Maharaj Singh; M Riccardo Colella; Richard A Rovin Journal: J Patient Cent Res Rev Date: 2022-04-18
Authors: Matthew E Ehrlich; Bin Han; Michael Lutz; Mohsen Ghiasi Ghorveh; Yasmin Ali Okeefe; Shreyansh Shah; Brad J Kolls; Carmelo Graffagnino Journal: Neurohospitalist Date: 2021-04-20
Authors: Boris Keselman; Annika Berglund; Niaz Ahmed; David Grannas; Mia von Euler; Staffan Holmin; Ann-Charlotte Laska; Jan M Mathé; Christina Sjöstrand; Einar E Eriksson; Michael V Mazya Journal: Eur Stroke J Date: 2022-02-23
Authors: Natalia Pérez de la Ossa; Sònia Abilleira; Tudor G Jovin; Álvaro García-Tornel; Xavier Jimenez; Xabier Urra; Pere Cardona; Dolores Cocho; Francisco Purroy; Joaquin Serena; Luis San Román Manzanera; Rosa Maria Vivanco-Hidalgo; Mercè Salvat-Plana; Angel Chamorro; Miquel Gallofré; Carlos A Molina; Erik Cobo; Antoni Davalos; Marc Ribo Journal: JAMA Date: 2022-05-10 Impact factor: 157.335
Authors: Theresa Williamson; Sarah Hodges; Lexie Zidanyue Yang; Hui-Jie Lee; Mostafa Gabr; Beatrice Ugiliweneza; Maxwell Boakye; Christopher I Shaffrey; C Rory Goodwin; Isaac O Karikari; Shivanand Lad; Muhammad Abd-El-Barr Journal: J Trauma Acute Care Surg Date: 2021-06-01 Impact factor: 3.697
Authors: Hooman Kamel; Neal S Parikh; Abhinaba Chatterjee; Luke K Kim; Jeffrey L Saver; Lee H Schwamm; Kori S Zachrison; Raul G Nogueira; Opeolu Adeoye; Iván Díaz; Andrew M Ryan; Ankur Pandya; Babak B Navi Journal: Stroke Date: 2021-05-13 Impact factor: 10.170
Authors: Derek Holder; Kevin Leeseberg; James A Giles; Sheyda Namazie; Andria L Ford; Jin-Moo Lee Journal: Stroke Date: 2021-06-22 Impact factor: 10.170
Authors: Kori S Zachrison; Sijia Li; Mathew J Reeves; Opeolu Adeoye; Carlos A Camargo; Lee H Schwamm; Renee Y Hsia Journal: Stroke Vasc Neurol Date: 2020-11-11